ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $650,211 | -12.3% | 59,380 | +6.0% | 0.00% | -50.0% |
Q2 2023 | $741,361 | -69.2% | 55,994 | -68.3% | 0.00% | -60.0% |
Q1 2023 | $2,406,547 | -39.1% | 176,822 | -12.6% | 0.01% | -44.4% |
Q4 2022 | $3,951,759 | -42.5% | 202,343 | -43.9% | 0.01% | -47.1% |
Q3 2022 | $6,875,000 | -25.0% | 360,881 | -18.9% | 0.02% | -19.0% |
Q2 2022 | $9,169,000 | +141.3% | 445,110 | +276.9% | 0.02% | +200.0% |
Q1 2022 | $3,800,000 | – | 118,085 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |